The Efficacy and Safety of Docetaxel Combined With Platinum for Metastatic Hormone-sensitive Prostate Cancer
Status:
Recruiting
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
This randomized controlled trial was designed to evaluate the efficacy and safety of
Docetaxel combined with Platinum-based drugs compared with Docetaxel alone for metastatic
hormone-sensitive prostate cancer patients carrying DNA repair mutation.
Phase:
Phase 2
Details
Lead Sponsor:
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School